Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Simvastatin Ammonium Salt
2. 139893-43-9
3. Simvastatin Hydroxy Acid Ammonium Salt
4. (3s,5s)-simvastatin Hydroxy Acid Ammonium Salt
5. 1-naphthaleneheptanoic Acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2,6-dimethyl-, Ammonium Salt (1:1), (betar,deltar,1s,2s,6r,8s,8ar)-
6. (3r,5r)-7-[(1s,2s,6r,8s,8ar)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic Acid Ammonium Salt (tenivastatin Ammonium Salt)
7. Tenivastatin Ammonium Salt
8. Mls006010119
9. Akos025149640
10. Smr004701253
11. Q27266499
12. (3r,5r)-7-((1s,2s,6r,8s,8ar)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic Acid, Ammonia Salt
| Molecular Weight | 453.6 g/mol |
|---|---|
| Molecular Formula | C25H43NO6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 453.30903809 g/mol |
| Monoisotopic Mass | 453.30903809 g/mol |
| Topological Polar Surface Area | 105 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 694 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Mls006010119 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mls006010119, including repackagers and relabelers. The FDA regulates Mls006010119 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mls006010119 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mls006010119 supplier is an individual or a company that provides Mls006010119 active pharmaceutical ingredient (API) or Mls006010119 finished formulations upon request. The Mls006010119 suppliers may include Mls006010119 API manufacturers, exporters, distributors and traders.
click here to find a list of Mls006010119 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mls006010119 DMF (Drug Master File) is a document detailing the whole manufacturing process of Mls006010119 active pharmaceutical ingredient (API) in detail. Different forms of Mls006010119 DMFs exist exist since differing nations have different regulations, such as Mls006010119 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mls006010119 DMF submitted to regulatory agencies in the US is known as a USDMF. Mls006010119 USDMF includes data on Mls006010119's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mls006010119 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mls006010119 suppliers with USDMF on PharmaCompass.
Mls006010119 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mls006010119 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mls006010119 GMP manufacturer or Mls006010119 GMP API supplier for your needs.
A Mls006010119 CoA (Certificate of Analysis) is a formal document that attests to Mls006010119's compliance with Mls006010119 specifications and serves as a tool for batch-level quality control.
Mls006010119 CoA mostly includes findings from lab analyses of a specific batch. For each Mls006010119 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mls006010119 may be tested according to a variety of international standards, such as European Pharmacopoeia (Mls006010119 EP), Mls006010119 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mls006010119 USP).
LOOKING FOR A SUPPLIER?
